Physician profile
Bill D Davis
NPI 1154352557
$793.26
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $167 · 2020: $84.58 · 2021: $119 · 2022: $153 · 2023: $125 · 2024: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $269.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $181.59 | 2021-2024 | Kyphon Express II Kyphopak Tray, Percept PC Brainsense, Sensight |
| Abbvie INC. | $157.16 | 2019-2024 | Botox |
| Abbott Laboratories | $139.29 | 2019-2023 | Infinity |
| Novo Nordisk INC | $74.61 | 2021 | |
| Allergan, INC. | $56.26 | 2020-2022 | |
| Livanova USA, INC. | $26.48 | 2019 | |
| Boston Scientific Corporation | $25.81 | 2022 | |
| Kyowa Kirin, INC. | $24.82 | 2019 | |
| Acadia Pharmaceuticals INC | $24.15 | 2022 | |
| Medtronic USA, INC. | $24.12 | 2019-2020 | |
| Ge Healthcare | $18.85 | 2022 | |
| Lilly USA, LLC | $17.16 | 2020 | |
| Neurocrine Biosciences, INC. | $12.07 | 2020 | |
| Acorda Therapeutics, INC | $10.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bill Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.